Quality by Design (QbD) refers to a holistic approach towards drug development. QbD has become the answer to assist both industry and FDA to move towards a more scientific, risk based, holistic and proactive approach to pharmaceutical development. The concept promotes industry’s understanding of the product and manufacturing process starting with product development, basically building quality ...

OBJECTIVES The aim of this study is to analyze the influence of the research and development (R&D) investment of pharmaceutical companies on enterprise value. METHODS The period of the empirical analysis is from 2000 to 2012, considering the period after the influence of the financial crisis. Financial statements and comments in general and internal transactions were extracted from TS-2000 of...

In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly highlighted in the pharmaceutical industry mainly because of a long development-time, low success r...

Previously, a number of world conferences have been arranged separately by the Ayurveda, Yoga, Naturopathy, Unani and Siddha medical fraternities, but this conference will discuss important issues related to all these ‘Indian Systems of Medicine’ under one roof for the very fi rst time. Academicians, scientists, pharmaceutical company representatives, and policy makers from all fraternities wil...

Study of ethical behavior among medical representatives in the profession is an under-portrayed component that deserves further perusal in the pharmaceutical industry. The purpose of this study is to find out the influence of organizational culture on ethical behavior of medical representatives. Medical representatives working for both domestic and multinational companies constitutes the sample...

this study seek to examine performance of feltham - ohlsen (1995)valuation model at the tehran stock exchange and is trying to identify relation between intrinsic company value and return. this model is trying to determine the intrinsic value of company using their book value. statistical community of this study includes all tse accepted companies and statistical sample is including 37 tse acce...

In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly highlighted in the pharmaceutical industry mainly because of a long development-time, low success r...

According to the Egyptian Ministry of Health, the per capita use of prescription drugs in Egypt is amongst the highest in the world. Multinational pharmaceutical companies license their proprietary products for manufacture and sale in Egypt through their Egyptian subsidiaries. A Ministry of Health Committee reviews and approves for sale all drugs marketed in the country. Aside from being an ext...

Competition throughout the business world is currently very tight and also development of information technology fast by requiring companies to have new innovations creations use all which can certainly maintain market consumers they have, then each industry must formulate strategic plans so that policies taken be effective efficient, not only planning in general field, but field systems greatl...